ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Chulin Sha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.